The demonstrated device used two forms of detection utilising chemiluminescence and fluorescence to detect different markers of interest
Acrongenomics and Molecular Vision (MVL) - an Imperial College spin-out company - announce the successful demonstration of their BioLED lab on a chip technology using MVL's patented, organic semiconductor technology in a high sensitivity, small size, medical diagnostic device that took place at Imperial College in London, UK on 8 March 2007.
The device demonstrated its technological capability to measure biomarkers with high sensitivity and at low cost.
BioLED technology uses semiconductor films located on either side of a microfluidics chip.
One film illuminates the chip, where appropriate, while the other film detects an output signal, which is fed to a display.
The demonstrated device used two forms of detection utilizing chemiluminescence and fluorescence to detect different markers of interest.
Acrongenomics and Molecular Vision believe that this technology is capable of further miniaturisation along with large scale, low cost manufacturing, which will bring forward disposable, point of care diagnostics for a large range of biomarkers.
Furthermore the companies presented possible design concepts of BioLED technology applications to be used at home, in doctor's offices and hospitals.
